DOC
Healthpeak Properties, Inc.
NYSE · Real Estate · REIT - Healthcare Facilities · US
$19.99
+2.17%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.1B | 2.8B | 2.7B | 2.2B | 2.1B |
| Cost of Revenue | 3.0B | 2.2B | 1.1B | 902.1M | 863.0M |
| Gross Profit | 102.3M | 634.5M | 1.6B | 1.3B | 1.2B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 94.3M | 90.4M | 97.2M | 95.1M | 131.0M |
| General & Admin Expense | 94.3M | 90.4M | 97.2M | 95.1M | 131.0M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (489.3M) | — | 1.1B | 749.9M | 710.6M |
| Total Operating Expenses | (394.9M) | 90.4M | 1.2B | 845.0M | 841.6M |
| Cost and Expenses | 2.6B | 2.3B | 2.2B | 1.7B | 1.7B |
| Operating Income (EBIT) | 497.2M | 544.1M | 471.2M | 433.9M | 356.6M |
| Non-Operating | |||||
| Interest Income | 14.2M | — | — | — | — |
| Interest Expense | 344.1M | 305.2M | 280.4M | 200.3M | 172.9M |
| Net Interest Income | (329.9M) | (305.2M) | (280.4M) | (200.3M) | (172.9M) |
| Other Non-Op Income/Expense | (69.7M) | (433.8M) | (199.6M) | (108.8M) | 152.5M |
| Non-Operating Income (excl Interest) | (167.9M) | 128.6M | (82.4M) | (81.4M) | (323.5M) |
| EBT (Pre-Tax Income) | 427.5M | 110.3M | 271.7M | 325.1M | 509.1M |
| Income Tax Expense | 6.2M | 9.3M | 4.3M | (9.6M) | (4.4M) |
| Bottom Line | |||||
| Net Income | 388.1M | 71.3M | 243.1M | 306.0M | 500.4M |
| Earnings from Cont. Ops | 421.4M | 101.0M | 267.3M | 334.8M | 513.5M |
| Earnings from Discont. Ops | — | — | — | — | 2.9M |
| Bottom Line Net Income | 377.1M | 70.5M | 242.4M | 304.3M | 497.8M |
| Per Share | |||||
| Basic EPS | $0.54 | $0.10 | $0.36 | $0.56 | $0.92 |
| Diluted EPS | $0.54 | $0.10 | $0.36 | $0.56 | $0.92 |
| Revenue Per Share | $4.44 | $4.06 | $4.00 | $3.99 | $3.83 |
| Shares | |||||
| Basic Shares Outstanding | 689.5M | 696.0M | 675.7M | 547.0M | 538.8M |
| Diluted Shares Outstanding | 689.5M | 696.0M | 676.2M | 547.3M | 539.1M |
| Profitability Metrics | |||||
| EBITDA | 1.8B | 1.4B | 1.6B | 1.3B | 1.4B |
| D&A | 1.1B | 1.0B | 1.1B | 749.9M | 710.6M |
| EBIT | 665.1M | 415.5M | 553.6M | 515.3M | 680.1M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026